WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998050015) DRY POWDER INHALER EXCIPIENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/050015    International Application No.:    PCT/BE1998/000064
Publication Date: 12.11.1998 International Filing Date: 07.05.1998
IPC:
A61K 47/26 (2006.01)
Applicants: PHARLYSE, SOCIETE ANONYME [LU/LU]; 2, boulevard Royal L-Luxembourg (LU) (For All Designated States Except US).
VANDERBIST, Francis [BE/BE]; (BE) (For US Only).
MAES, Paul [BE/BE]; (BE) (For US Only).
BAUDIER, Philippe [BE/BE]; (BE) (For US Only)
Inventors: VANDERBIST, Francis; (BE).
MAES, Paul; (BE).
BAUDIER, Philippe; (BE)
Agent: SCHMITZ, Yvon; Gevers Patents Holidaystraat 5 B-1831 Diegem (BE)
Priority Data:
97870065.6 07.05.1997 EP
Title (EN) DRY POWDER INHALER EXCIPIENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
(FR) EXCIPIENT POUR INHALATEUR A POUDRE SECHE, SON PROCEDE DE PREPARATION, ET COMPOSITIONS PHARMACEUTIQUES LE CONTENANT
Abstract: front page image
(EN)A pharmaceutical excipient useful in the formulation of dry powder inhaler compositions comprising a particulate roller-dried anhydrous $g(b)-lactose, said $g(b)-lactose particles having a size between 50 and 250 micrometers and a rugosity between 1.9 and 2.4, and the so formulated pharmaceutical compositions.
(FR)L'invention concerne un excipient pharmaceutique utile dans la formulation de compositions pour inhalateurs à poudre sèche, comprenant du $g(b)-lactose anhydre particulaire séché dans des cylindres. Les particules de $g(b)-lactose ont une taille comprise entre 50 et 250 $g(m)m et une rugosité comprise entre 1,9 et 2,4. L'invention concerne également les compositions pharmaceutiques ainsi formulées.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)